Key facts
- This page summarizes Rene Sindlev's Form 4 filing for RENOVARO BIOSCIENCES INC. (RENB).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Feb 2024, 18:38.
Rene Sindlev - 13 Feb 2024 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- RENB
- Reported as of
- 13 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Feb 2024, 18:38:55 UTC
- Prior SEC filing
- 12 Sep 2023
- Next SEC filing
- 22 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rene Sindlev
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rene Sindlev filed Form 4 for RENOVARO BIOSCIENCES INC. (RENB) on 15 Feb 2024.
Change
- Previous filing in this sequence was filed on 12 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RENB
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +701,260
- Change %
- +5.6%
- Price
- Shares after
- 13,133,598
- Date
- 13 Feb 2024
- Ownership
- By RS Bio ApS
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RENB
transaction
Derivative
Series A Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -70,126
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Feb 2024
- Ownership
- By RS Bio ApS
- Underlying class
- Common Stock
- Underlying amount
- 701,260
- Exercise price
- $0.000000
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of Common Stock on a one-for-ten basis pursuant to their terms. The automatic conversion was triggered by the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. The shares of Preferred Stock were initially acquired by the Reporting Person for $7.13 per share.
Footnote F2
The Preferred Stock is convertible into Common Stock on a one-for-ten basis.
Footnote F3
The Preferred Stock is perpetual and has no expiration date.